Cargando…
Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas
INTRODUCTION: Clinical outcomes for mucosal melanomas are often poor due to a lack of effective systemic drug therapies. Identifying driver genes in mucosal melanoma may enhance the understanding of disease pathogenesis and provide novel opportunities to develop effective therapies. RESULTS: Somatic...
Autores principales: | Quek, Camelia, Rawson, Robert V., Ferguson, Peter M., Shang, Ping, Silva, Ines, Saw, Robyn P.M., Shannon, Kerwin, Thompson, John F., Hayward, Nicholas K., Long, Georgina V., Mann, Graham J., Scolyer, Richard A., Wilmott, James S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398173/ https://www.ncbi.nlm.nih.gov/pubmed/30847022 http://dx.doi.org/10.18632/oncotarget.26584 |
Ejemplares similares
-
High-Dimensional Single-Cell Transcriptomics in Melanoma and Cancer Immunotherapy
por: Quek, Camelia, et al.
Publicado: (2021) -
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
por: Harbour, J. William, et al.
Publicado: (2013) -
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
por: Newell, Felicity, et al.
Publicado: (2019) -
Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma
por: Hintzsche, Jennifer D., et al.
Publicado: (2017) -
Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients
por: Gide, Tuba N., et al.
Publicado: (2019)